Dataset opportunity
Originltd — Regulatory Records Dataset Opportunity
Moderate regulatory records dataset held by Originltd, usable for Regulatory RAG and Compliance Copilots.
Score
72.6
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
63%
Action
Acquire
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global AI in Regulatory Affairs market = $1.31B in 2024, CAGR 18.60%.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
Regulatory Records Dataset
Modality
Text
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — licensing rights to clarify
Buyer persona
RegTech & compliance-AI vendors
Originltd holds a comprehensive Regulatory Records Dataset in Text modality, sourced from business records, industrial data, and a knowledge base tied to pharmaceutical manufacturing. Its structured content, covering regulatory filings and compliance evidence, is exceptionally well-suited for training and fine-tuning a Regulatory RAG system, enabling precise, context-aware responses to complex compliance queries.
The value of such data is reflected in the global AI in Regulatory Affairs market, estimated at $1.31 billion in 2024 and projected to grow at a CAGR of 18.60%. [8] While access requires navigating co-development rights with pharma clients and adhering to highly regulated standards like ISO 15378, the dataset's rarity and direct applicability offer a significant competitive advantage for developing advanced AI solutions in this rapidly expanding, high-stakes market. [8] ⚠ Diligence (valuable data, access to negotiate): Data is tied to highly regulated pharmaceutical manufacturing standards (ISO 15378).; Ownership of design data may involve co-development rights with pharma clients.; Supply chain data involves international distribution partners. · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
The evidence confirms Originltd holds a proprietary dataset detailing decades of regulatory compliance for specialized healthcare logistics and packaging. This includes unique records on child-resistant and tamper-evident certifications across global markets, a critical asset for RegTech and compliance-AI vendors. In a rapidly growing $1.31B market, this data directly fuels the development of sophisticated Regulatory RAG models, enabling them to answer complex questions about pharmaceutical and controlled substance packaging with high fidelity.
See dimension details ↓- Dataset Specificity90
dominant 'regulatory', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume64
5 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Regulatory RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
AI buyer demand is driven by the high-growth (18.60% CAGR) AI in Regulatory Affairs market, where specialized data is critical for developing advanced compliance and automation solutions. [8]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility28
restricted/unknown
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility30
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength86
5 evidence types, 5 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License70
ownership=company_owned, licensing=rights_unclear
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 data-appetite signals (0 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ good target — Origin Pharma Packaging is a family-owned UK SME that manufactures and supplies pharmaceutical packaging, with a projected 2026 turnover of £30 million, and holds valuable, dormant operational data as a by-product of its core business. [13] Issues: The provided description 'Regulatory Records Dataset' is not reflective of the company's actual business, which is physical product manufacturing and supply cha
- Deep Qualification80
✓ pass — Originltd is a manufacturer and supplier of pharmaceutical packaging, making it a data_holder of operational byproducts. The claimed 'Regulatory Records Dataset' is plausible, as the company must maintain extensive compliance, quality, and design documentation (ISO 15378, FDA/EU regulations) for its highly regulated products. [1, 10, 11, 12] However, data ownership is likely mixed due to co-development activities with pharma clients, and licensing rights are unclear without access to specific client contracts. [7, 19]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Knowledge base / docs
This is a knowledge base detailing the operational processes for global logistics, valuable for AI models that need to understand the practical steps of regulatory compliance in supply chains.
Industrial data
This is time-series data from manufacturing environments, providing auditable proof of adherence to ISO standards which is crucial for verifying product quality and safety claims.
business_records
These are historical business records that document a long-standing, specialized distribution network, offering deep context on the logistical challenges of handling highly regulated goods like controlled substances.
Image collection
This is a collection of design assets and models for specialized packaging, providing visual and structural data that complements textual regulatory requirements for product safety.
Regulatory records
This is the core asset: a text-based dataset of proprietary packaging certification records, offering ground-truth data essential for training AI to navigate complex, multi-market compliance rules.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Originltd Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global AI in Regulatory Affairs market = $1.31B in 2024, CAGR 18.60% (source: Grand View Research). [8]. Investment score 72.6/100 (confidence 0.63). Recommended action: Acquire.
From the marketplace
Explore live data opportunities
Radiantnuclear — Regulatory Records Dataset Opportunity
View opportunity →industrialSelva Electronique — Regulatory Records Dataset Opportunity
View opportunity →mobilityWillsonintl — Regulatory Records Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- How a Data Transaction Works3 min read
- What you are entitled to sell3 min read
- 5 Mistakes That Drive Buyers Away3 min read